S SERVIER
Updates & Highlights
Oncodaily · 4 days ago
Olivier Laureau: Welcoming Edgewise Therapeutics to Servier and Opening a New Chapter for Patients
Law360 · 4 days ago
UK Gov't Bodies Step Up Pay-For-Delay Claim Against Servier
BioXconomy · 5 days ago
Sanofi and Servier execs talk oncology: Pitches, Europe's position, and China's advantage
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at SERVIER?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentOlivier Laureau: Welcoming Edgewise Therapeutics to Servier and Opening a New Chapter for Patients
Olivier Laureau: Welcoming Edgewise Therapeutics to Servier and Opening a New Chapter for Patients
Oncodaily · 4 days ago
UK Gov't Bodies Step Up Pay-For-Delay Claim Against Servier
UK Gov't Bodies Step Up Pay-For-Delay Claim Against Servier
Law360 · 4 days ago
Sanofi and Servier execs talk oncology: Pitches, Europe's position, and China's advantage
Sanofi and Servier execs talk oncology: Pitches, Europe's position, and China's advantage
BioXconomy · 5 days ago
Supporting Caregivers at the Heart of Glioma Care – Servier
Supporting Caregivers at the Heart of Glioma Care – Servier
Oncodaily · 7 days ago
What Just Happened with Day One Biopharmaceuticals and Servier
What Just Happened with Day One Biopharmaceuticals and Servier
Kavout | AI · 8 days ago
Advancing Targeted Therapies for Rare Cancers – Servier
Advancing Targeted Therapies for Rare Cancers – Servier
Oncodaily · 8 days ago
Servier targeted by fresh claims from UK health authorities
Servier targeted by fresh claims from UK health authorities
MLex · 9 days ago
Fostering a Strong, People-First Culture – Servier Pharmaceuticals
Fostering a Strong, People-First Culture – Servier Pharmaceuticals
Oncodaily · 9 days ago
Resilience in the Face of Brain Cancer: Christelle and Martin’s Story – Servier
Resilience in the Face of Brain Cancer: Christelle and Martin’s Story – Servier
Oncodaily · 9 days ago
What Does Servier's $2.5 Billion Acquisition Mean for Day One Biopharmaceuticals
What Does Servier's $2.5 Billion Acquisition Mean for Day One Biopharmaceuticals
Kavout | AI · 10 days ago
Advancing Precision Therapies for Patients With Cancer in Japan – Servier
Advancing Precision Therapies for Patients With Cancer in Japan – Servier
Oncodaily · 12 days ago
Why Did Servier Pay a 68% Premium for Day One Biopharmaceuticals
Why Did Servier Pay a 68% Premium for Day One Biopharmaceuticals
Kavout | AI · 14 days ago
White & Case advises Servier on financing for Edgewise Therapeutics acquisition and revolving credit facility refinancing
White & Case advises Servier on financing for Edgewise Therapeutics acquisition and revolving credit facility refinancing
White & Case LLP · 16 days ago
World Cup Semi-Finals Bring Colleagues Together in Boston – Servier Pharmaceuticals
World Cup Semi-Finals Bring Colleagues Together in Boston – Servier Pharmaceuticals
Oncodaily · 16 days ago
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier
Pulse 2.0 · 19 days ago
Servier Acquires Muscular Dystrophy Business from Edgewise Therapeutics
Servier Acquires Muscular Dystrophy Business from Edgewise Therapeutics
Contract Pharma · 20 days ago
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
PR Newswire · 20 days ago
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Yahoo Finance · 26 days ago
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Pharmaceutical Technology · 26 days ago
Servier Invites to Explore Precision Medicine and Real-World Evidence in Cholangiocarcinoma at ESMO GI 2026
Servier Invites to Explore Precision Medicine and Real-World Evidence in Cholangiocarcinoma at ESMO GI 2026
Oncodaily · about 1 month ago